A protective role by interleukin-17f in colon tumorigenesis

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Tong, Zan ^a   Yang, Xuexian O ^b,c   Yan, Huichao ^a   Liu, Weihuang ^a   Niu, Xiaoyin ^b   Shi, Yun ^b   Fang, Wenfeng ^a   Xiong, Bing ^a   Wan, Yu ^a   Dong, Chen ^b  

^a WUHAN UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; INTERLEUKIN 17F; VASCULOTROPIN; INTERLEUKIN 17; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER INHIBITION; CLINICAL ARTICLE; COLON CANCER; COLON CARCINOGENESIS; COLON MUCOSA; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE LEVEL; TISSUE SECTION; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; CELL STRAIN HCT116; CELL TRANSFORMATION; COLON TUMOR; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; NEOVASCULARIZATION (PATHOLOGY);

MUS; MUS MUSCULUS;

ANIMALS; ANTIGENS, CD31; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; INTERLEUKIN-17; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84859578124     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034959     Document Type: Article

References (33)

1. Starnes T, Robertson MJ, Sledge G, Kelich S, Nakshatri H, et al. (2001) Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J Immunol 167: 4137-4140.
2. Kawaguchi M, Onuchic LF, Li XD, Essayan DM, Schroeder J, et al. (2001) Identification of a novel cytokine, ML-1, and its expression in subjects with asthma. J Immunol 167: 4430-4435.
3. Kolls JK, Linden A, (2004) Interleukin-17 family members and inflammation. Immunity 21: 467-476.
4. Moseley TA, Haudenschild DR, Rose L, Reddi AH, (2003) Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 14: 155-174.
5. Dong C, (2008) TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 8: 337-348.
6. Akimzhanov AM, Yang XO, Dong C, (2007) Chromatin remodeling of interleukin-17 (IL-17)-IL-17F cytokine gene locus during inflammatory helper T cell differentiation. J Biol Chem 282: 5969-5972.
7. Chang SH, Dong C, (2007) A novel heterodimeric cytokine consisting of IL-17 and IL-17F regulates inflammatory responses. Cell Res 17: 435-440.
8. Wright JF, Guo Y, Quazi A, Luxenberg DP, Bennett F, et al. (2007) Identification of an interleukin 17F/17A heterodimer in activated human CD4+ T cells. J Biol Chem 282: 13447-13455.
9. Weaver CT, Hatton RD, Mangan PR, Harrington LE, (2007) IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 25: 821-852.
10. Kuestner RE, Taft DW, Haran A, Brandt CS, Brender T, et al. (2007) Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F. J Immunol 179: 5462-5473.
11. Chang SH, Dong C, (2009) IL-17F: regulation, signaling and function in inflammation. Cytokine 46: 7-11.
12. Seiderer J, Elben I, Diegelmann J, Glas J, Stallhofer J, et al. (2008) Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD. Inflamm Bowel Dis 14: 437-445.
13. Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, et al. (2003) Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52: 65-70.
14. Yang XO, Chang SH, Park H, Nurieva R, Shah B, et al. (2008) Regulation of inflammatory responses by IL-17F. J Exp Med 205: 1063-1075.
15. Ogawa A, Andoh A, Araki Y, Bamba T, Fujiyama Y, (2004) Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin Immunol 110: 55-62.
16. Ishigame H, Kakuta S, Nagai T, Kadoki M, Nambu A, et al. (2009) Differential roles of interleukin-17A and-17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 30: 108-119.
17. Murugaiyan G, Saha B, (2009) Protumor vs antitumor functions of IL-17. J Immunol 183: 4169-4175.
18. Tartour E, Fossiez F, Joyeux I, Galinha A, Gey A, et al. (1999) Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer Res 59: 3698-3704.
19. Numasaki M, Watanabe M, Suzuki T, Takahashi H, Nakamura A, et al. (2005) IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J Immunol 175: 6177-6189.
20. Hirahara N, Nio Y, Sasaki S, Minari Y, Takamura M, et al. (2001) Inoculation of human interleukin-17 gene-transfected Meth-A fibrosarcoma cells induces T cell-dependent tumor-specific immunity in mice. Oncology 61: 79-89.
21. Benchetrit F, Ciree A, Vives V, Warnier G, Gey A, et al. (2002) Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism. Blood 99: 2114-2121.
22. Martin-Orozco N, Muranski P, Chung Y, Yang XO, Yamazaki T, et al. (2009) T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity 31: 787-798.
23. Le Gouvello S, Bastuji-Garin S, Aloulou N, Mansour H, Chaumette MT, et al. (2008) High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas. Gut 57: 772-779.
24. Su X, Ye J, Hsueh EC, Zhang Y, Hoft DF, et al. (2010) Tumor microenvironments direct the recruitment and expansion of human Th17 cells. J Immunol 184: 1630-1641.
25. Chae WJ, Gibson TF, Zelterman D, Hao L, Henegariu O, et al. (2010) Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis. Proc Natl Acad Sci U S A 107: 5540-5544.
26. Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, et al. (2009) A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 15: 1016-1022.
27. Numasaki M, Fukushi J, Ono M, Narula SK, Zavodny PJ, et al. (2003) Interleukin-17 promotes angiogenesis and tumor growth. Blood 101: 2620-2627.
28. Coussens LM, Werb Z, (2002) Inflammation and cancer. Nature 420: 860-867.
29. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, et al. (2004) IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118: 285-296.
30. Xie Y, Sheng W, Xiang J, Ye Z, Yang J, (2010) Interleukin-17F suppresses hepatocarcinoma cell growth via inhibition of tumor angiogenesis. Cancer Invest 28: 598-607.
31. Fajardo LF, Kwan HH, Kowalski J, Prionas SD, Allison AC, (1992) Dual role of tumor necrosis factor-alpha in angiogenesis. Am J Pathol 140: 539-544.
32. Hymowitz SG, Filvaroff EH, Yin JP, Lee J, Cai L, et al. (2001) IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. Embo J 20: 5332-5341.
33. Grivennikov S, Karin E, Terzic J, Mucida D, Yu GY, et al. (2009) IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15: 103-113.